glp 1 novo With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins Novo Nordisk asks FDA not

[1] According to the SmPC, semaglutide undergoes proteolytic degradation and beta-oxidation with metabolites excreted in urine and faeces

Immediate weight loss and ongoing progress: She started losing weight almost immediately

Papilosome Enriched Media

Practical implications For patients who develop allodynia on one GLP-1 medication, switching to a different medication within the class (or to a different formulation of the same medication) is a reasonable strategy to try

And, I expect this cohort to get pretty big, because GLP-1 patients have mismatched expectations (fuelled by social media and AI slop), believing they should be dropping 20lbs a month on these drugs